Leucovorin endorsement for autism by FDA falls through. What’s next?


Leucovorin endorsement for autism by FDA falls by way of. What’s subsequent?

In September, officers touted leucovorin as a possible therapy for 1000’s of youngsters with autism. Now the FDA is strolling again from that declare because the drug is accepted for a uncommon genetic situation, not autism. NCS’s Meg Tirrell stories.



Sources

Leave a Reply

Your email address will not be published. Required fields are marked *